Clinical Trials Browser

INDUSTRY × Interventional × Neurocognitive Disorders × Clear all

NCT05522387 2026-02-27

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Phase 2 Terminated

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT05633095 2023-03-24

The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early Dementia

Phase NA Unknown

Dementia, Lymphoma, Follicular, Neurocognitive Disorders